Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosa
Alexander Simonis(University of Cologne), Jan Rybniker(Integrated Oncology (United States)), Biao Yuan(Universität Hamburg), Christoph Kreer(University of Cologne), Katharina Rox(German Center for Infection Research), Christina Meyer(University of Cologne), Sebastian J. Theobald(University of Cologne), Gerd Fätkenheuer(University of Cologne), Manuel Koch(University Hospital Cologne), Kristin Schmitt(University of Cologne), Silke van Koningsbruggen‐Rietschel(University of Cologne), Sandra Winter(University of Cologne), Michael Hallek(Integrated Oncology (United States)), Harald Seifert(German Center for Infection Research), Thomas C. Marlovits(Universität Hamburg), Meike Meyer(University of Cologne), Anna‐Maria Hellmann(University of Cologne), Florian Klein(University of Cologne), Alexandra Albus(University of Cologne), Meryem S. Ercanoglu(University of Cologne), Lisa Kottege(University of Cologne), Dmitriy Holzmann(University of Cologne), Nina Cramer(Medizinische Hochschule Hannover), Joana A. Wilms(University of Cologne), Sylvia Zuber(University of Cologne), Henning Gruell(University of Cologne), Ernst Rietschel(University of Cologne), Antje Munder(BioClinica (United States))
Cited by 55
Related Papers
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by <i>Staphylococcus aureus</i>
|New England Journal of Medicine|2006|1.5k